Therapeutics Solutions International Inc., an Oceanside-based company developing treatments for cancer and other diseases, announced Wednesday that Dr. Hong Ma has been appointed as chief scientific officer.
Ma comes from life science consulting group Chinese Business Partners, where she worked as managing partner and founder for the past six years. Before that, she worked at BioScience Ventures Inc. as a business development associate.
Ma has an extensive history in academic and translational research. She has over 20 peer-reviewed publications and has worked with institutions in the U.S., China, and Japan, according to a Therapeutic Solutions news release. She received her medical degree from Dalian Medical University, her doctorate in cardiovascular pharmacology from Asahikawa Medical College, and her master's degree in business administration from the Rady School of Management at the University of California, San Diego.